国产99久久精品_欧美日本韩国一区二区_激情小说综合网_欧美一级二级视频_午夜av电影_日本久久精品视频

英國 Menarini Diagnostics  
意大利Menarini制藥旗下診斷公司,1987年在英國成立
 

MENARINI DIAGNOSTICS COMPANY PROFILE
Menarini is one of Europe's leading pharmaceutical and healthcare companies, with headquarters in Florence and research facilities in Pomezia, near Rome. The organisation, which was incorporated over 100 years ago has over forty subsidiaries operating throughout Eastern and Western Europe, with a network of marketing partners covering other countries around the world. The Menarini group consists of pharmaceutical, over the counter medicine and diagnostic divisions, as well as several other divisions concerned with bio-medical measurement. The Menarini group turnover during 2009 was over ￡2 billion, with further expansion across the world planned during 2010.

Menarini Diagnostics was established in the UK during 1987. The Company is now established as one of the fastest growing Diagnostics companies in the UK with annual growth in excess of 20%. To date Menarini has already placed more than 700 analysers of various types in the UK market. We are market leaders in the field of Diabetes Diagnostics, with leading edge systems for HbA1c, blood glucose and continuous glucose monitoring. We are also growing rapidly in the areas of Immunohistochemistry, Autoimmune disease and near patient systems for veterinary diagnostics.

The company has achieved this growth by an emphasis on promoting leading edge products, and combining that with high quality service and technical support. Menarini UK currently employs over 80 staff in sales, marketing and customer support. The company is based in Wokingham, Berkshire in a purpose built facility which includes offices, warehousing and engineering workshops. During 2004 Menarini Diagnostics UK, in common with all of the other Menarini affiliates, achieved certification to the International Quality Standard ISO 9000:2000 and in 2008 also achieved ISO 13485; the company is committed to continuous improvement in quality in all of its activities.